VeraCyte Obtains $28,000,000 Series B Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6a862e28-195f-4de0-93af-7be7f7f7a518&Preview=1 - Date
6/10/2010 - Company Name
VeraCyte - Mailing Address
Undisclosed South San Francisco, CA 94080 - Company Description
Operates as an early stage cancer diagnostics company. - Website
Undisclosed
- Transaction Type
Venture Equity - Transaction Amount
$28,000,000 - Transaction Round
Series B - Proceeds Purposes
This investment will be used to bring our advanced testing service in thyroid cancer to market by the end of this year. - M&A Terms
- Venture Investor
Domain Associates - Venture Investor
Versant Ventures - Venture Investor
Versant Ventures - Venture Investor
Kleiner Perkins Caufield & Byers - Venture Investor
TPG Biotechnology Partners
